Literature DB >> 3680507

Rapid formation of large molecular weight alpha-polymers in cross-linked fibrin induced by high factor XIII concentrations. Role of platelet factor XIII.

C W Francis1, V J Marder.   

Abstract

After fibrin polymerization, activated Factor XIII catalyzes the formation of intermolecular cross-links between gamma-chain pairs and also among two or more alpha-chains to form polymers. In this report we characterize the size and heterogeneity of alpha-chain polymers, establish the role of high concentrations of Factor XIII in determining the extent and rate of alpha-polymer formation, and also provide evidence that the Factor XIII required can be provided by platelets. Fibrin prepared from purified fibrinogen or platelet-deficient plasma contained a series of cross-linked alpha-chain polymers with Mr from 140,000 to 770,000 with a mean Mr difference of 32,000 consistent with a staggered, overlapping addition of monomers to the growing alpha-polymer chain. In plasma containing no platelets, alpha-polymer formation was incomplete with residual alpha-monomer remaining, but higher platelet counts facilitated more rapid cross-linking into larger polymers. Purified Factor XIII was equally effective as platelets in facilitating cross-linking. We conclude that cross-linked alpha-polymer chains are heterogeneous in size reaching a molecular weight of several million and that high concentrations of Factor XIII as provided by platelets are required for maximum cross-linking.

Entities:  

Mesh:

Substances:

Year:  1987        PMID: 3680507      PMCID: PMC442404          DOI: 10.1172/JCI113226

Source DB:  PubMed          Journal:  J Clin Invest        ISSN: 0021-9738            Impact factor:   14.808


  45 in total

1.  Fibrin crosslinks and lysis rates.

Authors:  P J Gaffney; A N Whitaker
Journal:  Thromb Res       Date:  1979-01       Impact factor: 3.944

2.  High molecular weight derivatives of human fibrinogen produced by plasmin. I. Physicochemical and immunological characterization.

Authors:  V J Marder; N R Shulman; W R Carroll
Journal:  J Biol Chem       Date:  1969-04-25       Impact factor: 5.157

3.  Fibrin-stabilizing factor: a thrombin-labile platelet protein.

Authors:  T H Kiesselbach; R H Wagner
Journal:  Am J Physiol       Date:  1966-12

4.  Molecular weight determination of protein-dodecyl sulfate complexes by gel electrophoresis in a discontinuous buffer system.

Authors:  D M Neville
Journal:  J Biol Chem       Date:  1971-10-25       Impact factor: 5.157

5.  The reliability of molecular weight determinations by dodecyl sulfate-polyacrylamide gel electrophoresis.

Authors:  K Weber; M Osborn
Journal:  J Biol Chem       Date:  1969-08-25       Impact factor: 5.157

6.  Subunit structure of human fibrinogen, soluble fibrin, and cross-linked insoluble fibrin.

Authors:  P A McKee; P Mattock; R L Hill
Journal:  Proc Natl Acad Sci U S A       Date:  1970-07       Impact factor: 11.205

7.  The influence of fibrin crosslinking on the kinetics of urokinase-induced clot lysis.

Authors:  R P McDonagh; J McDonagh; F Duckert
Journal:  Br J Haematol       Date:  1971-09       Impact factor: 6.998

8.  The cold-insoluble globulin of human plasma. I. Purification, primary characterization, and relationship to fibrinogen and other cold-insoluble fraction components.

Authors:  M W Mosesson; R A Umfleet
Journal:  J Biol Chem       Date:  1970-11-10       Impact factor: 5.157

9.  Epsilon-(gamma glutamyl) lysine in fibrin: lack of crosslink formation in Factor 13 deficiency.

Authors:  J J Pisano; J S Finlayson; M P Peyton; Y Nagai
Journal:  Proc Natl Acad Sci U S A       Date:  1971-04       Impact factor: 11.205

10.  Diagnostic and genetic studies on fibrin-stabilizing factor with a new assay based on amine incorporation.

Authors:  L Lorand; T Urayama; J W De Kiewiet; H L Nossel
Journal:  J Clin Invest       Date:  1969-06       Impact factor: 14.808

View more
  12 in total

1.  NMR solution structure, stability, and interaction of the recombinant bovine fibrinogen alphaC-domain fragment.

Authors:  Robert A Burton; Galina Tsurupa; Roy R Hantgan; Nico Tjandra; Leonid Medved
Journal:  Biochemistry       Date:  2007-06-23       Impact factor: 3.162

2.  Influence of a natural and a synthetic inhibitor of factor XIIIa on fibrin clot rheology.

Authors:  E A Ryan; L F Mockros; A M Stern; L Lorand
Journal:  Biophys J       Date:  1999-11       Impact factor: 4.033

3.  On the mechanism of αC polymer formation in fibrin.

Authors:  Galina Tsurupa; Igor Pechik; Rustem I Litvinov; Roy R Hantgan; Nico Tjandra; John W Weisel; Leonid Medved
Journal:  Biochemistry       Date:  2012-03-15       Impact factor: 3.162

4.  The mouse dorsal skinfold chamber as a model for the study of thrombolysis by intravital microscopy.

Authors:  Yacine Boulaftali; Lamia Lamrani; Marie-Catherine Rouzaud; Stéphane Loyau; Martine Jandrot-Perrus; Marie-Christine Bouton; Benoît Ho-Tin-Noé
Journal:  Thromb Haemost       Date:  2012-03-08       Impact factor: 5.249

Review 5.  The molecular origins of the mechanical properties of fibrin.

Authors:  Michael R Falvo; Oleg V Gorkun; Susan T Lord
Journal:  Biophys Chem       Date:  2010-11       Impact factor: 2.352

6.  Transglutaminase-mediated oligomerization of the fibrin(ogen) alphaC domains promotes integrin-dependent cell adhesion and signaling.

Authors:  Alexey M Belkin; Galina Tsurupa; Evgeny Zemskov; Yuri Veklich; John W Weisel; Leonid Medved
Journal:  Blood       Date:  2005-01-06       Impact factor: 22.113

7.  Factor XIII in plasma, but not in platelets, mediates red blood cell retention in clots and venous thrombus size in mice.

Authors:  Sravya Kattula; James R Byrnes; Sara M Martin; Lori A Holle; Brian C Cooley; Matthew J Flick; Alisa S Wolberg
Journal:  Blood Adv       Date:  2018-01-03

8.  Functional factor XIII-A is exposed on the stimulated platelet surface.

Authors:  Joanne L Mitchell; Ausra S Lionikiene; Steven R Fraser; Claire S Whyte; Nuala A Booth; Nicola J Mutch
Journal:  Blood       Date:  2014-10-20       Impact factor: 22.113

9.  Plasma factor XIII activity in patients with disseminated intravascular coagulation.

Authors:  Jae Woo Song; Jong Rak Choi; Kyung Soon Song; Ji-Hyuk Rhee
Journal:  Yonsei Med J       Date:  2006-04-30       Impact factor: 2.759

10.  Mild Acquired Factor XIII Deficiency and Clinical Relevance at the ICU-A Retrospective Analysis.

Authors:  Felix Carl Fabian Schmitt; Maik von der Forst; Wolfgang Miesbach; Sebastian Casu; Markus Alexander Weigand; Sonja Alesci
Journal:  Clin Appl Thromb Hemost       Date:  2021 Jan-Dec       Impact factor: 2.389

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.